Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. NVDA
2. PCG
3. AMZN
4. AAPL
5. AVGO
6. ALNY
7. CNS
8. STLA
9. EC
10. SPCX

Go back to Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.37 +0.11 (1.19%)
Previous Close $9.26    52 Week High $9.23 
Open $9.10    52 Week Low $1.16 
Day High $9.99    P/E N/A 
Day Low $9.09    EPS $-0.30 
Volume 7,271,525